{"SPADE_UN_13418": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13418", "Peptide Name": "[D9K]Hymenochirin-1B", "Source": "Synthetic construct", "Family": "N/A", "Gene": "N/A", "Sequence": "IKLSPETKKNLKKVLKGAIKGAIAVAKMV", "Sequence Length": 29, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notfound"], "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Anticancer"], "Target Organism": "[Ref.24172540] Gram-positive bacteria:S. aureus ATCC 29213 (MIC = 3.1 μM), S. aureus ATCC 25923 (MIC = 3.1 μM), S.epidermidis RP62A (MIC = 1.6 μM), S.epidermidis RP62A/1 (MIC = 0.8 μM), C.albicans ATCC 90028 (MIC = 50 μM);Gram-negative bacteria:E.coli (MIC = 6.25 μM), A. baumannii (MIC = 3.1 μM), S. maltophilia (MIC = 3.1 μM), K. pneumoniae (MIC = 12.5 μM), P. aeruginosa (MIC = 25 μM), P.mirabilis (MIC > 100 μM).[Ref.30789695] Cancer cell lines:A549 (IC50 = 1.82 ± 0.23 μM), HCT116 (IC50 = 6.50 ± 0.32 μM), HepG2 (IC50 = 4.96 ± 0.43 μM).", "Hemolytic Activity": "[Ref.24172540] LC₅₀ = 174 ± 12 μM against freshly prepared human erythrocytes.", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "No structure indentification experiment and detailed structure description found", "Formula": "C141H258N38O35S", "Mass": 3077.86, "PI": 10.48, "Net Charge": 7, "Hydrophobicity": 0.16, "Half Life": "Mammalian:20 hourYeast:30 minE.coli:>10 hour", "Function": "Antibacterial activity against Gram-positive and Gram-negative bacteria; Anticancer activity.", "Comments": "Ref.30789695 does not include results of antimicrobial, hemolysis and other biological assays", "Literature": [{"Title": "An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties.", "Pubmed ID": "24172540", "Reference": "Peptides. 2013 Dec;50153-9. doi 10.1016/j.peptides.2013.10.015. Epub 2013 Oct 27.", "Author": "Milena Mechkarska, Manju Prajeep, Gordana D Radosavljevic, Ivan P Jovanovic, Amna Al Baloushi, Agnes Sonnevend, Miodrag L Lukic, J Michael Conlon.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=24172540"}, {"Title": "Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B A Novel Glycosylated Staple Strategy.", "Pubmed ID": "30789695", "Reference": "ACS Chem Biol. 2019 Mar 15;14(3)516-525. doi 10.1021/acschembio.9b00046. Epub 2019 Mar 1.", "Author": "Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=30789695"}, {"Title": "Anti-tumor activities of the host-defense peptide hymenochirin-1B", "Pubmed ID": "", "Author": "Attoub S, Arafat K, Mechkarska M, Conlon JM"}, {"Title": "An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties", "Pubmed ID": "", "Author": "Mechkarska M, Prajeep M, Radosavljevic GD, Jovanovic IP, Al Baloushi A, Sonnevend A, Lukic ML, Conlo"}], "Frequent Amino Acids": "KAI", "Absent Amino Acids": "CDFHOQRUWY", "Basic Residues": 8, "Acidic Residues": 1, "Hydrophobic Residues": 15, "Polar Residues": 18, "Positive Residues": 8, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13423", "Similarity": 1.0, "Sequence": "IKLSPETKKNLKKVLKGAIKGAIAVAKMV"}, {"SPADE_ID": "SPADE_UN_23804", "Similarity": 1.0, "Sequence": "IKLSPTKKLKKVLKGAIKGAIAVAKMV"}, {"SPADE_ID": "SPADE_UN_23808", "Similarity": 1.0, "Sequence": "IKLSPTKKLKKVLKGIKGIAVAKMV"}]}}}